Moreover, even if IDH mutation is considered one of the most important drivers of chondrosarcoma, other genes seem to be involved in tumor progression (p53, Rb, histone deacetylase, and others) and may impact on patient prognosis. This evidence concerns the gene TP53 and chondrosarcoma.